Zobrazeno 71 - 80
of 346
pro vyhledávání: '"Pär Stattin"'
Autor:
Walter, Cazzaniga, Rebecka Arnsrud, Godtman, Stefan, Carlsson, Göran, Ahlgren, Eva, Johansson, David, Robinson, Jonas, Hugosson, Pär, Stattin
Publikováno v:
Journal of Surgical Oncology
Introduction Radical prostatectomy (RP) is a common surgical procedure with a risk of postoperative erectile dysfunction and urinary incontinence. There is a need for data on RP as a basis for quality assurance and benchmarking. Methods In 2015, pros
Autor:
Elin Axén, I Franck-Lissbrant, Per Fransson, Pär Stattin, Ali Khatami, K Koss-Modig, M. Nyberg, Jonas Hugosson, Maria Frånlund, Ola Bratt, Pär Lodding, Johan Stranne
Publikováno v:
World Journal of Urology
PURPOSE: The demand for objective and outcome-based facts about surgical results after radical prostatectomy (RP) is increasing. Systematic feedback is also essential for each surgeon to improve his/her performance. METHODS: RP outcome data (e.g., pT
Autor:
Isabel Drake, Tone Bjørge, Sara Ghaderi, Håkan Jonsson, Alois Lang, Pär Stattin, Tanja Stocks, Gabriele Nagel, Jonas Manjer, Christel Häggström, Hanno Ulmer, Anders Engeland
Publikováno v:
International Journal of Cancer
Apart from the consistently observed differential association between obesity and breast cancer risk by menopausal status, the associations between obesity and other metabolic imbalances with risks of cancers have not been systematically investigated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6762c62cd9603eedf7d4da20f15f024b
http://hdl.handle.net/11250/2594749
http://hdl.handle.net/11250/2594749
Autor:
Tone Bjørge, Björn Gylling, Jonas Manjer, Christel Häggström, Josef Fritz, Hans Concin, Alois Lang, Pär Stattin, Anders Engeland, Hanno Ulmer, Gabriele Nagel, Stanley Teleka, Tanja Stocks, Steinar Tretli
Publikováno v:
International Journal of Epidemiology
Background The role of insulin resistance as a mediator in the association of body mass index (BMI) with site-specific cancer risk has, to our knowledge, never been systematically quantified. Methods Altogether 510 471 individuals from six European c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d0cd31b56533f45277b6a11e0b0de66
https://hdl.handle.net/11250/3011495
https://hdl.handle.net/11250/3011495
Autor:
Pär Stattin, Gincy George, Lars Holmberg, Hans Garmo, Sarah Rudman, Mieke Van Hemelrijck, David Robinson, Jan Adolfsson
Aim: Gonadotropin-releasing hormone (GnRH) agonists are used to treat men with prostate cancer (PCa). To date, no study has fully assessed patterns of adherence to GnRH agonists. We investigated patterns of adherence to GnRH agonists using data from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a3b2fab43c703391b503cceb5a9da8e
Autor:
Hans Garmo, Jan-Erik Damber, J. Adolfsson, David Robinson, Lars-Olof Wahlund, M. Van Hemelrijck, Pär Stattin, Ola Bratt, Lars Holmberg
Objectives To study whether androgen deprivation therapy (ADT), the mainstay treatment for advanced and disseminated prostate cancer, is associated with risk of dementia. Methods Risk of dementia in men with prostate cancer primarily managed with ADT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e180fa0297cf70cc16b7e31136501dc1
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-388761
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-388761
Autor:
Erik Bovinder Ylitalo, Pär Stattin, Sead Crnalic, Patrik Rydén, Lars Egevad, Elin Thysell, Diego Iglesias-Gato, Pernilla Wikström, Linda Vidman, Anders Bergh, Anders Widmark, Emma Jernberg, Amilcar Flores-Morales
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 13, Iss 8, Pp 1763-1777 (2019)
Molecular Oncology, Vol 13, Iss 8, Pp 1763-1777 (2019)
Bone metastasis is the lethal end‐stage of prostate cancer (PC), but the biology of bone metastases is poorly understood. The overall aim of this study was therefore to explore molecular variability in PC bone metastases of potential importance for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0e6012670f05bf5872cdf985bc95773
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-393124
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-393124
Autor:
Niklas Hammar, Cecilia Bosco, Mieke Van Hemelrijck, Hans Garmo, Jan Adolfsson, Frederik Birkebæk Thomsen, Pär Stattin
Publikováno v:
Thomsen, F B, Bosco, C, Garmo, H, Adolfsson, J, Hammar, N, Stattin, P & Van Hemelrijck, M 2018, ' Anti-androgen monotherapy versus Gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer : a register-based, observational study ', Acta Oncologica . https://doi.org/10.1080/0284186X.2018.1529427
Background: In randomised controlled trials, men with advanced, non-metastatic prostate cancer (PCa) treated with anti-androgen monotherapy (AA) had similar all-cause mortality as men treated with gonadotropin-releasing hormone (GnRH) agonists. Using
Autor:
Pär Stattin, Abbas Chabok, Kenneth Smedh, Ingvar Sverrisson, Maziar Nikberg, Folke Folkvaljon
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 45(3)
There are little data on the post-operative outcome of anterior resection (AR) for rectal cancer in men who had received radiotherapy for prostate cancer previously. The aim of this study was to assess the rate of anastomotic leakage (AL) after AR in
Autor:
Linda Drevin, Jonas Sandberg, Pär Stattin, David Robinsson, Stefan Carlsson, Andreas Josefsson, Ola Bratt, Erik Holmberg, Eva Johansson, Ove Andrén, Maria Nyberg
Publikováno v:
European urology. 76(4)
A systematic repeat biopsy is recommended for men starting on active surveillance for prostate cancer, but the optimal number and distribution of cores are unknown.To evaluate an extensive repeat transrectal biopsy with anterior sampling in men start